Ignite Creation Date:
2024-07-17 @ 10:58 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06463548
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-18
First Post:
2024-06-03
Brief Title:
Irinotecan Hydrochloride Liposome Combined With Capecitabine and Lenvatinib in Patients With Biliary Tract Carcinoma
Sponsor:
Yunpeng Liu
Organization:
China Medical University China
Organization Data
Organization:
China Medical University China
Class:
OTHER
Study ID:
CSPC-DEY-BTC-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Yunpeng Liu
Lead Sponsor Class:
OTHER
Responsible Party:
Yunpeng Liu
Responsible Party Title:
Director
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
China Medical University China
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| CSPC Ouyi Pharmaceutical Co Ltd | INDUSTRY |